This page may have documents that can’t be read by screen reader software. For help with these documents, please call 1-800-975-6314.

COVID-19 Update: Treatment Cost-Share Waiver Extended

October 15, 2020

We continue to monitor the COVID-19 pandemic and are committed to helping our employer customers and members stay informed. We have an update to the treatment cost-share waiver end date. As always, members should call the number on their ID card for answers to their specific benefit questions. 

  • The cost-share waiver for treatment will be extended through Dec. 31, 2020.

Currently, there is no projected end date for the Office of Superintendent of Insurance (OSI) rule that requires cost-share waiver for COVID-19-related testing and treatment for fully insured and Interagency Benefits Advisory Council (IBAC) members.

Initiative

Effective Date

Projected End Date

COVID-19 Testing

3/7/20

Cost-share waiver ends with the end of the Health and Human Services (HHS) public health emergency

For fully insured and IBAC members: There is no end date for New Mexico’s rule requiring cost-share waiver for COVID-19-related testing and treatment

COVID-19 Testing-related Visits

3/18/20

Cost-share waiver ends with the end of HHS public health emergency

For fully insured and IBAC members: There is no end date for New Mexico’s rule requiring cost-share waiver for COVID-19-related testing and treatment.

Telehealth/Telemedicine

3/18/20

Cost-share waiver will end on 12/31/20. (The requirements of the OSI will continue to apply to COVID-19-related testing and treatment delivered by telemedicine for fully insured and IBAC members.)

For Medicare (not Part D) and Medicare Supplement plans: Cost-share waiver will end 12/31/20

COVID-19 Treatment

4/1/20

Cost-share waiver extended through 12/31/20* (and beyond 12/31/20 for COVID-19-related testing and treatment for fully insured and IBAC members)

*Date change/extension

As we let you know in April, self-funded customers (ASO) who aligned with Blue Cross and Blue Shield of New Mexico (BCBSNM) decisions for fully insured members would continue that alignment unless we were notified.

  • BCBSNM will extend the cost-share waiver for treatment through Dec. 31, 2020. 

What this means for ASO groups

Your prior decision to waive cost-share for treatment will be extended through Dec. 31, 2020, unless you make a request to BCBSNM to end the cost-share waiver.

If you would like to make a change from your original decision, please contact your account executive no later than Friday, Oct. 16. If you don’t communicate that change by Oct. 16, your decision will continue as currently coded. Change decisions made after Oct. 16 cannot be accommodated for a Nov. 1, 2020, effective date.

COVID-19 Testing and the CARES Act

 As a reminder, COVID-19 testing and testing-related visits are covered at no cost-share for fully insured and ASO members until the end of the federal public health emergency, as required by the Families First Coronavirus Response Act.